Teva Pharmaceutical Industries Free Cash Flow 2010-2024 | TEVA

Teva Pharmaceutical Industries free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Teva Pharmaceutical Industries annual free cash flow for 2023 was $0.91B, a 18.02% decline from 2022.
  • Teva Pharmaceutical Industries annual free cash flow for 2022 was $1.11B, a 102.93% increase from 2021.
  • Teva Pharmaceutical Industries annual free cash flow for 2021 was $0.547B, a 22.41% decline from 2020.

Teva Pharmaceutical Industries Free Cash Flow 2010-2024 | TEVA

  • Teva Pharmaceutical Industries annual free cash flow for 2023 was $0.91B, a 18.02% decline from 2022.
  • Teva Pharmaceutical Industries annual free cash flow for 2022 was $1.11B, a 102.93% increase from 2021.
  • Teva Pharmaceutical Industries annual free cash flow for 2021 was $0.547B, a 22.41% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M